In mid-May, the secretary of the Health Departmentthe doctor Carlos Mellado revealed that he suffered from the condition of carcinoid syndrome and was receiving chemotherapy treatment to combat the disease, the symptoms of which, in his case, had appeared a year ago.
Mellado explained that the symptoms he has experienced include swelling of the hands, pain, fatigue and facial redness. Unlike other diseases, carcinoid syndrome is rarely discussed and perhaps there are more patients with the condition or presenting symptoms that may be a warning to immediately seek medical attention.
El Nuevo Dia consulted with the hematologist and oncologist Anna Di Marco, who treats patients with this condition and explained to us what carcinoid syndrome is and how it affects a person’s life.
Carcinoid syndrome is a group of symptoms associated with a tumor called neuroendocrine, also known as carcinoid tumor. Carcinoid tumors secrete a high amount of the hormone serotonin, which acts as a neurotransmitter. The hormones cause blood vessels to dilate, and that is when the first symptoms of carcinoid syndrome begin to appear.
“In fact, the tumor is called neuroendocrine or carcinoid and causes symptoms called carcinoid syndrome. Most carcinoid tumors are found in the gastrointestinal tract, in the colon and rarely in the lung, but they can be present in the lungs. That is why there are patients who have had intestinal problems for a long time and many times these tumors originate mainly in the intestine, in the colon. This neuroendocrine tumor is very rare and according to American statistics 4 in 100,000 adults can develop a neuroendocrine tumor and of those, one in 300,000 can have the syndrome, so having the syndrome is even rarer.“said the oncologist who does not know the current health status of the Secretary of the Department of Health, since he is not her patient.
However, at the Women’s Cancer Center in Ponce, the doctor has patients who have been diagnosed with carcinoid syndrome for up to ten years and are still under treatment. This is because carcinoid tumor is slow growing.
“Carcinoid tumors grow very slowly, very slowly. They almost never metastasize. But when they do, they go to the liver and the lung. I have patients with metastases that have been there for almost 9 to 10 years, who are dealing with the symptoms and undergoing treatment. The spread is also slow,” explained the oncologist and hematologist.
Di Marco said that neuroendocrine tumors are one of the few tumors that secrete serotonin and that, according to the patients he has seen in his practice, the main and most common symptoms are: inflammation, redness of the face and chest, to the point of feeling a “hot flash” and constant diarrhea.
The doctor also said that patients can have “10 to 20 bouts of diarrhea a day, it is uncontrollable.” Other symptoms include difficulty breathing, because serotonin causes bronchospasm in the lung, high or low blood pressure, problems with the heart valves and palpitations.
The hematologist and oncologist stressed that anyone who begins to experience any of these symptoms should go to a doctor for the required tests. One of the tests for early detection is colonoscopy and the presence of the symptoms mentioned above.
Once a diagnosis of carcinoid syndrome has been made and a tumor is identified, the suggested treatment is surgery to remove the primary tumor. It is vital to identify the primary tumor.
“After surgery, even if the tumor has been completely removed, the person may have carcinoid syndrome because there may be small cells there, which are secreting serotonin and giving you symptoms,” added the health professional.
At the treatment level, it is administered an octreotide injection once a months, subcutaneously or in “cases of crisis it can be intravenous four times a day.” It also includes cycles of chemotherapy and immunotherapy treatment.
“Oncology today is a very advanced science and we treat patients individually. So, what does this mean? We send the pathology to the United States for molecular testing, and depending on these findings, we can opt for more modern treatments such as immunotherapy. There is immunotherapy for carcinoids using (drugs) novolumab and pembrolizumab, among others. I have patients who are receiving these immunotherapies,” he said.
Di Marco emphasized that each patient is treated individually and that, since it is such a rare and slow-growing tumor, “people, even with metastasis, live for many years with the tumor.”
“Thank God, none of those patients with carcinoid tumors have died. Because it is slow-growing, once metastatic, It is a cancer with which the patient must learn to live and manage the symptoms.“he concluded.
